All you need to know as vaccine withdrawn from use after deaths

Need to know All you need to know as vaccine withdrawn from use after deaths MHRA has withdrawn the vaccine following a safety review that found its benefits no longer outweigh its risks All you need to know as vaccine withdrawn from UK use after serious side effects and deaths: - Health officials have withdrawn a chikungunya vaccine after a safety review found its risks now outweigh its benefits. - The Medicines and Healthcare products Regulatory Agency (MHRA) has told professionals to stop prescribing and administering IXCHIQ, a live vaccine for adults travelling to areas where the virus is common. - Serious reactions have included chikungunya-like symptoms and rare neurological complications such as encephalitis, with some cases leading to hospitalisation or death. Cases were mainly reported among older adults and those with underlying health conditions, but also occurred in people with no known medical issues. - The MHRA confirmed that people who have had the vaccine without side effects do not need further treatment or revaccination, adding: "Any individuals who have previously received IXCHIQ vaccination and experienced side effects are advised to seek medical advice and report to the Yellow Card scheme." - Chikungunya virus is an infection transmitted to humans primarily through the bite of infected Aedes mosquitoes. These mosquitoes are typically active during daylight hours, particularly shortly after sunrise and around dusk. - Travellers are advised to consider other ways to reduce their risk, including alternative vaccines, mosquito repellent and netting, and to check the latest travel health guidance. READ THE FULL STORY: Vaccine withdrawn from use in UK after deaths reported